Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by Plato5on Jul 26, 2010 3:05pm
451 Views
Post# 17297554

RE: Is Lux in a bad spot?

RE: Is Lux in a bad spot?Four good questions from teevee. I presume that any response must be purely speculative. it will all depend on the reasons for the delay - if there is a delay.

If it is clear from the FDA decision that the drug is certainly a go - pending the resolution of issues which can clearly be addressed, ISA will certainly be able to raise any necessary bridge funding needed to bring to the drug to market - even if in the form of a loan. ISA generated good will with its quick pay pack of a loan last year.
<< Previous
Bullboard Posts
Next >>